These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20833947)

  • 1. Methylene blue and serotonin toxicity: definite causal link.
    Gillman PK
    Psychosomatics; 2010; 51(5):448-9. PubMed ID: 20833947
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient Safety and Methylene Blue-Associated Severe Serotonin Toxicity.
    Rosenbaum HK; Gillman PK
    A A Case Rep; 2016 Jul; 7(1):1. PubMed ID: 27415030
    [No Abstract]   [Full Text] [Related]  

  • 3. Serotonin syndrome following Methylene Blue infusion: a rare complication of antidepressant therapy.
    Héritier Barras AC; Walder B; Seeck M
    J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1412-3. PubMed ID: 20547626
    [No Abstract]   [Full Text] [Related]  

  • 4. CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity.
    Gillman PK
    J Psychopharmacol; 2011 Mar; 25(3):429-36. PubMed ID: 20142303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal methylene blue associated serotonin toxicity.
    Top WM; Gillman PK; de Langen CJ; Kooy A
    Neth J Med; 2014 Apr; 72(3):179-81. PubMed ID: 24846936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium.
    Stanford SC; Stanford BJ; Gillman PK
    J Psychopharmacol; 2010 Oct; 24(10):1433-8. PubMed ID: 19423610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In reference to Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use.
    Gillman K
    Laryngoscope; 2010 Feb; 120(2):436-7. PubMed ID: 19950381
    [No Abstract]   [Full Text] [Related]  

  • 8. An easily overlooked cause of toxic encephalopathy: methylene blue in a patient on an SSRI.
    Honoré PJ; Deianova N; Loret G; Hemelsoet D
    Acta Neurol Belg; 2018 Mar; 118(1):121-122. PubMed ID: 28748330
    [No Abstract]   [Full Text] [Related]  

  • 9. The monoamine oxidase inhibition properties of selected structural analogues of methylene blue.
    Delport A; Harvey BH; Petzer A; Petzer JP
    Toxicol Appl Pharmacol; 2017 Jun; 325():1-8. PubMed ID: 28377303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of methylene blue in serotonin syndrome: a systematic review.
    Ng BK; Cameron AJ
    Psychosomatics; 2010; 51(3):194-200. PubMed ID: 20484716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylene blue-induced serotonin syndrome presenting with ocular clonus and failure of emergence from general anesthesia.
    Nicolaou G; Lee D
    Can J Anaesth; 2016 Jul; 63(7):896-7. PubMed ID: 26943644
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in intensity of serotonin syndrome caused by adverse interaction between monoamine oxidase inhibitors and serotonin reuptake blockers.
    Tao R; Rudacille M; Zhang G; Ma Z
    Neuropsychopharmacology; 2014 Jul; 39(8):1996-2007. PubMed ID: 24577320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin toxicity precipitated by concomitant use of citalopram and methylene blue.
    Khavandi A; Whitaker J; Gonna H
    Med J Aust; 2008 Nov; 189(9):534-5. PubMed ID: 18976207
    [No Abstract]   [Full Text] [Related]  

  • 14. [Life-threatening serotonin syndrome following a single dose of a serotonin reuptake inhibitor during maintenance therapy with a monoamine oxidase inhibitor].
    Güzelcan Y; Kleinpenning AS
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1748; author reply 1748-9. PubMed ID: 16927475
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
    Eur J Pharmacol; 2006 Feb; 532(3):258-64. PubMed ID: 16488409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin syndrome resulting from drug interactions.
    Chan BS; Graudins A; Whyte IM; Dawson AH; Braitberg G; Duggin GG
    Med J Aust; 1998 Nov; 169(10):523-5. PubMed ID: 9861909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. eComment: Serotonin syndrome: pharmacogenomics and treatment.
    Koniari I; Tsigkas G; Apostolakis E
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):657-8. PubMed ID: 18664669
    [No Abstract]   [Full Text] [Related]  

  • 18. A Case of Serotonin Syndrome Caused by the Concomitant Utilization of Methylene Blue and Venlafaxine in an Oncological Patient.
    Gilbert B; Akamune IE
    J Pharm Pract; 2020 Oct; 33(5):705-707. PubMed ID: 31232145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin syndrome following methylene blue infusion during parathyroidectomy: a case report and literature review.
    Ng BK; Cameron AJ; Liang R; Rahman H
    Can J Anaesth; 2008 Jan; 55(1):36-41. PubMed ID: 18166746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The serotoninergic syndrome: moclobemide and citalopram].
    Gumà M; Clemente F; Segura A; Costa J
    Med Clin (Barc); 1999 Nov; 113(17):677-8. PubMed ID: 10618787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.